scholarly journals Pannexin 1 involvement in bladder dysfunction in a multiple sclerosis model

2013 ◽  
Vol 3 (1) ◽  
Author(s):  
Hiromitsu Negoro ◽  
Sarah E. Lutz ◽  
Louis S. Liou ◽  
Akihiro Kanematsu ◽  
Osamu Ogawa ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Bladder Dysfunction ◽  
Pannexin 1 ◽  
Multiple Sclerosis Model

36 A PUTATIVE MECHANISM FOR PANNEXIN 1 INVOLVEMENT IN BLADDER DYSFUNCTION IN AN ANIMAL MODEL OF MULTIPLE SCLEROSIS

2013 ◽  
Vol 189 (4S) ◽  
Author(s):  
Hiromitsu Negoro ◽  
Sarah Lutz ◽  
Eliana Scemes ◽  
Sylvia Suadicani
Keyword(s):  
Multiple Sclerosis ◽  
Animal Model ◽  
Bladder Dysfunction ◽  
Pannexin 1 ◽  
Putative Mechanism

Management of bladder dysfunction in multiple sclerosis patients: the nurse’s point of view

2008 ◽  
Vol 29 (S4) ◽  
pp. 356-359 ◽  
Author(s):  
Roberta Motta ◽  
Maria Laura Lopes de Carvalho
Keyword(s):  
Multiple Sclerosis ◽  
Bladder Dysfunction ◽  
Point Of View ◽  
Multiple Sclerosis Patients

Oligoprotective effect of metformin through the AMPK-dependent on restoration of mitochondrial hemostasis in the cuprizone-induced multiple sclerosis model

2019 ◽  
Vol 50 (3) ◽  
pp. 263-271 ◽  
Author(s):  
Seyed Hossein Hosseini Largani ◽  
Maryam Borhani-Haghighi ◽  
Parichehr Pasbakhsh ◽  
Vahid Pirhajati Mahabadi ◽  
Saied Nekoonam ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Multiple Sclerosis Model

scholarly journals Latent-period stool proteomic assay of multiple sclerosis model indicates protective capacity of host-expressed protease inhibitors

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Carlos G. Gonzalez ◽  
Stephanie K. Tankou ◽  
Laura M. Cox ◽  
Ellen P. Casavant ◽  
Howard L. Weiner ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Latent Period ◽  
Protease Inhibitors ◽  
Protective Capacity ◽  
Multiple Sclerosis Model

Wrong cytokine backed in multiple-sclerosis model

2003 ◽  
Vol 2 (4) ◽  
pp. 203 ◽  
Author(s):  
Jane Bradbury
Keyword(s):  
Multiple Sclerosis ◽  
Multiple Sclerosis Model

Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4+ T cell CTLA-4 expression

2020 ◽  
Vol 338 ◽  
pp. 577105 ◽  
Author(s):  
Justin A. Spanier ◽  
Faye E. Nashold ◽  
Corwin D. Nelson ◽  
Corinne E. Praska ◽  
Colleen E. Hayes
Keyword(s):  
Multiple Sclerosis ◽  
T Cell ◽  
Vitamin D3 ◽  
Myeloid Cell ◽  
Cd4 T Cell ◽  
Dihydroxyvitamin D3 ◽  
1,25 Dihydroxyvitamin D3 ◽  
Multiple Sclerosis Model

Mononuclear phagocytes locally specify and adapt their phenotype in a multiple sclerosis model

2018 ◽  
Vol 21 (9) ◽  
pp. 1196-1208 ◽  
Author(s):  
Giuseppe Locatelli ◽  
Delphine Theodorou ◽  
Arek Kendirli ◽  
Marta Joana Costa Jordão ◽  
Ori Staszewski ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Mononuclear Phagocytes ◽  
Multiple Sclerosis Model

scholarly journals Mesenchymal properties of SJL mice-stem cells and their efficacy as autologous therapy in a relapsing–remitting multiple sclerosis model

2014 ◽  
Vol 5 (6) ◽  
pp. 134 ◽  
Author(s):  
Carmen Marin-Bañasco ◽  
Margarita García ◽  
Issac Guerrero ◽  
Rafael Sánchez ◽  
Guillermo Estivill-Torrús ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Stem Cells ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Autologous Therapy ◽  
Relapsing Remitting Multiple Sclerosis ◽  
Multiple Sclerosis Model
Sign in / Sign up

Export Citation Format

Share Document